SCHEMBL4228913

SCHEMBL4228913

CCOC(=O)c1nc(Nc2cccc(OC(=O)n3ccnc3)c2)nc2c1[nH]c(=O)n2-c1ccccc1OC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
GLA P06280 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 2/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HDAC3 O15379 10/20 0.40
HDAC4 P56524 10/20 0.40
HDAC1 Q13547 10/20 0.40
HDAC7 Q8WUI4 10/20 0.40
HDAC2 Q92769 10/20 0.40
HDAC10 Q969S8 10/20 0.40
HDAC11 Q96DB2 10/20 0.40
HDAC8 Q9BY41 10/20 0.40
HDAC6 Q9UBN7 10/20 0.40
HDAC9 Q9UKV0 10/20 0.40
HDAC5 Q9UQL6 10/20 0.40
KMT2A Q03164 1/20 0.36
CSF1R P07333 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4223540 0.94 KDM4E (0.44) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL1749830 0.82 KDM4E (0.49) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL4228313 0.82 KDM4E (0.44) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL4220429 0.82 KDM4E (0.44) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL4220426 0.82 KDM4E (0.44) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL1749220 0.73 KDM4E (0.46) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL300795 0.73 KDM4E (0.59) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL301308 0.73 KDM4E (0.57) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL4225570 0.72 KDM4E (0.50) KDM4EGLAALDH1A1HPGDGAA
SCHEMBL300607 0.72 KDM4E (0.59) KDM4EGLAALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078018-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS Signal Pharmaceuticals LLC (US) 2009-07-15 EP disclosed
WO-2008051494-A1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND USE THEREOF AS PROTEIN KINASE INHIBITORS SIGNAL PHARMACEUTICALS, LLC (US) 2008-05-02 WO disclosed